Personal finance site SmartAsset recently examined what income ranges qualify as middle class across the United States, using a common benchmark: households earning between two-thirds and double the ...

A study reveals 45% of Kashmir students face mental health issues linked to social media, urging interventions for healthier usage.

Atea Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.49. Operator: ...

A coalition of 24 states has filed a lawsuit challenging President Donald Trump’s latest round of tariffs, setting up another legal battle over the administration’s trade policy just weeks after the ...

Instead of banning AI, why don't schools teach students to use it critically? College freshman Maximilian Milovidov shares what he has learned in an "AI writing" course at Columbia University.

Students and family alike were invited to Warren County Middle School (WCMS) on Tuesday evening for STEM Family Engagement Night, which is held each semester.

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...

Data readout for SIM0505/CDH6 ADC Phase 1 dose escalation study and initiation of dose optimization in ovarian cancer are both anticipated in Q2 2026LNCB74 Phase 1 dose escalation trial update planned ...

On March 12, Faith Sisters Bible Study and Fellowship meet at 7 p.m. Visit fccmanhattan.org for more information. Join us for worship in person at 10:45 a.m. Sunday. Rev. Caela Simmons Wood will ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, 'Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today ...

HLP004 is an investigational intramuscular deuterated serotonergic agonist designed to activate serotonin pathways believed to promote neuroplasticity. The program is being developed as a potential ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately ...